Month: March 2023

Flow Cytometer Market Analysis: Current Trends and Future Projections

The domain of novel cell cytometers, particularly flow cytometer, has attracted much attention within the global biopharmaceutical industry in recent years. This popularity can be attributed mainly to the need of these tools to address the rising prevalence of chronic disease conditions. Flow cytometers allow simultaneous characterization of cells from a mixed population, thereby helping

Clinical Trial Recruitment – Determinant of Successful Clinical Trials

Clinical trials are a fundamental requirement for evaluating the safety and efficacy of novel therapeutic interventions. Initiating a clinical trial is a complex and time-consuming process, involving suitable planning and execution. In addition, there are several other challenges, including inefficiencies related to data handling, and difficulties associated with patient engagement solutions, which further complicates the

AI Pathology: Key Trends and Opportunities

How is AI being used in Digital Pathology? AI pathology is a transformative technology that has enabled pathologists to make the shift from visual inspection of tissue samples to automated image analysis. With the advent of artficial intelligence pathology, researchers are now benefiting from computerized image analysis software that can draw conclusions and deliver diagnoses

Introduction To Exosome Therapeutics

In  recent years, therapies utilizing extracellular vesicles have garnered significant attention among the industry stakeholders for the treatment of diverse target indication, primarily owing to the various benefits offered by them, including target specificity, enhanced tissue regeneration, and reduced inflammation and chronic pain. Over time, various research studies have demonstrated the potential of exosomes (membrane

Women’s Health Market: The Rising Investment Opportunities

Digital health is a broad term that refers to the utilization of communication and information technologies to manage, track, and improve the overall healthcare delivery system. As a part of the growing digital therapeutics market to optimize patient healthcare and the development of pharmaceuticals, the women’s health market has witnessed significant rise in investments in

Genotoxicity Testing: The Future Safety Assessment Opportunities

Genotoxicity testing refers to the evaluation of detrimental effects of chemical or physical agents on the genetic processes and related hereditary material of living cells. On the other hand, mutagenicity is the process of inducing irreversible and transmissible alterations in the genetic material of organisms either spontaneously or through mutagenic activity. Disruption of the integrity